Paediatric meningoencephalitis in the molecular diagnostic era: Epidemiological insights from 1,198 suspected cases in Germany between 2016 and 2024

This retrospective study of 1,198 pediatric patients in Germany (2016–2024) reveals that bacterial meningitis is now rare compared to viral and unresolved cases, highlighting the utility of the UK-ChiMES clinical prediction score in guiding diagnostic and therapeutic decisions in the era of multiplex PCR diagnostics.

The Gist

Imagine a hospital emergency room as a busy airport terminal. Every day, hundreds of children arrive with symptoms that look like a storm is brewing in their brains: high fevers, confusion, seizures, or stiff necks. Doctors are the air traffic controllers here. Their job is to figure out: Is this a harmless drizzle (a virus), a dangerous hurricane (bacteria), or just a weird weather pattern we can't explain yet?

For years, the fear was always that a "hurricane" (bacterial meningitis) was coming, so doctors would open the gates wide and run a very specific, invasive test called a Lumbar Puncture (LP)—essentially taking a tiny sample of the fluid around the brain—to be safe.

This paper is a report card from a German children's hospital (Dr. von Hauner Children's Hospital) looking at 1,198 kids who went through this process between 2016 and 2024. They used a high-tech "super-sniffer" (multiplex PCR) that can instantly detect dozens of germs at once.

Here is the story of what they found, told in simple terms:

1. The "Hurricane" is Rare

The biggest surprise? Bacterial meningitis is incredibly rare now.
Out of 1,198 kids, only 13 (about 1%) actually had the dangerous bacterial kind.

• The Analogy: Imagine you are checking 100 suitcases at an airport for bombs. In the old days, you might find a few. Now, thanks to vaccines (which act like a force field against the big bad bacteria), you are almost never finding them. In this study, you'd have to check 92 suitcases just to find one "bomb."

2. The "Drizzle" is Everywhere

Instead of hurricanes, the hospital was flooded with "drizzle" (viruses).

• Enteroviruses and Parechoviruses were the most common culprits. These are like the common cold of the brain. They make kids sick, but they usually go away on their own without needing heavy antibiotics.
• The Mystery Fog: A huge chunk of the kids (about 11% of all cases) had inflammation but no germ was found at all. It's like the brain is acting up, but the "super-sniffer" can't find the culprit. This is called "aseptic meningitis of unknown etiology."

3. The "Brain Fog" (Encephalitis) is Hard to Solve

Encephalitis is when the brain itself gets inflamed, causing confusion or personality changes.

• Even with the fancy new super-sniffer, doctors could only find the specific germ in less than half of these cases.
• The Metaphor: It's like trying to find a specific thief in a crowded room using a metal detector. Sometimes the metal detector beeps (we find the germ), but often the room is just chaotic, and we can't tell who started the trouble.

4. The "Magic Scorecards"

Since we can't test every kid for everything (it's too invasive and expensive), doctors use Scorecards (prediction tools) to guess who needs the scary "bomb check" (antibiotics) and who can go home.

The study tested three different scorecards:

• The Old Scorecard (BMS): It was good at saying "No bomb" (99.6% accurate at ruling it out), but it was bad at saying "Yes, bomb!" It cried wolf too often, leading to unnecessary treatments.
• The New Scorecards (UK-ChiMES): These are the new, upgraded GPS systems.
  • They are smarter. They look at things like vomiting, rash, and blood test results before even doing the spinal tap.
  • They are much better at distinguishing between a "drizzle" and a "hurricane."
  • The Result: The new scorecard (UK-ChiMES-pre-LP) is the best tool we have right now. It helps doctors feel confident enough to skip the spinal tap in kids who are likely just having a viral "drizzle," saving them from a painful procedure.

5. The "Blood Test" Clues

The researchers also looked at blood markers (like CRP and Procalcitonin).

• Think of these as the smoke alarms. When the "hurricane" (bacteria) hits, the smoke alarms go off loud and clear (very high numbers).
• When it's just a "drizzle" (virus) or a mystery, the alarms stay quiet or only beep softly.
• CRP was the best smoke alarm in this study.

The Bottom Line

Vaccines and better tests have changed the game.

• Then: Doctors were terrified of bacteria, so they tested everyone for it.
• Now: Bacteria are rare. Most kids have viruses or unknown causes.
• The Takeaway: We don't need to treat every child like they have a bacterial infection. By using the new UK-ChiMES scorecard, doctors can safely avoid unnecessary spinal taps and antibiotics for the vast majority of kids, focusing the heavy-duty treatments only on the very few who truly need them.

It's a shift from "scrape every suitcase for a bomb" to "use a smart scanner to spot the real threats," making the airport safer and less stressful for everyone.

Technical Summary

1. Problem Statement

Acute central nervous system (CNS) infections in children remain medical emergencies with high morbidity and mortality. Historically, bacterial meningitis was the primary concern, necessitating aggressive empirical treatment and invasive lumbar punctures (LP). However, the epidemiological landscape has shifted due to:

• Widespread conjugate vaccination: Significantly reducing invasive bacterial diseases (e.g., N. meningitidis, S. pneumoniae, H. influenzae type B).
• Advances in molecular diagnostics: The introduction of multiplex PCR panels allows for rapid, broad-spectrum pathogen detection.

Despite these shifts, there is a lack of contemporary, large-scale epidemiological data from the "molecular diagnostic era" to guide clinical decision-making. Clinicians currently lack updated risk stratification tools to distinguish between bacterial, viral, and aseptic meningitis, often leading to unnecessary LPs and prolonged antibiotic use. This study aims to characterize the current etiology of suspected pediatric meningoencephalitis and evaluate the diagnostic performance of existing clinical prediction scores (Bacterial Meningitis Score and UK-ChiMES scores) in a real-world cohort.

2. Methodology

• Study Design: Retrospective, single-center cohort study conducted at Dr. von Hauner Children's Hospital (LMU Munich, Germany).
• Population: 1,198 children and adolescents (<18 years) who underwent lumbar puncture with cerebrospinal fluid (CSF) multiplex PCR testing for suspected CNS infection between January 2016 and December 2024.
  • Exclusions: Ventricular shunts, recent neurosurgery, unsuccessful LPs, and repeat admissions.
• Diagnostic Tools:
  • Microbiology: BioFire® FilmArray® Meningitis/Encephalitis (ME) Panel was used for routine CSF analysis.
  • Classification: Cases were categorized using predefined criteria adapted from the UK-ChiMES network and International Encephalitis Consortium:
    • Definite Bacterial Meningitis: Pathogen identified in CSF/blood or positive Gram stain.
    • Definite Viral Meningitis: Pathogen identified in CSF/blood (or specific viruses like EV/Parechovirus/HSV in CSF regardless of WBC).
    • Aseptic Meningitis: CSF pleocytosis without identified pathogen.
    • Encephalitis: Classified as possible, probable, or confirmed based on clinical criteria (altered mental status, fever, seizures, etc.) and microbiological confirmation.
• Statistical Analysis: Descriptive statistics, non-parametric group comparisons, and Receiver Operating Characteristic (ROC) curve analysis were used to evaluate biomarkers (CRP, PCT, IL-6) and prediction scores (BMS, UK-ChiMES pre- and post-LP).

3. Key Contributions

• Contemporary Epidemiology: Provides the first large-scale, unbiased data from a German tertiary center reflecting the post-vaccination and multiplex PCR era.
• Validation of Prediction Scores: Offers an independent validation of the recently published UK-ChiMES scores (pre- and post-lumbar puncture) against the established Bacterial Meningitis Score (BMS) in a real-world setting.
• Biomarker Analysis: Systematically evaluates the discriminatory power of inflammatory markers (CRP, Procalcitonin, IL-6) specifically for distinguishing bacterial from non-bacterial CNS infections in children.
• Diagnostic Gap Identification: Highlights the persistent inability to identify an etiology in a significant proportion of encephalitis cases despite advanced molecular testing.

4. Key Results

• Etiological Distribution:
  • Total Cohort (n=1,198):
    • Definite Bacterial Meningitis: 1.1% (13 cases).
    • Definite Viral Meningitis: 6.7% (80 cases).
    • Aseptic Meningitis (Unknown Etiology): 11.0% (131 cases).
    • Confirmed/Probable Encephalitis: 4.4% (53 cases).
    • Possible Encephalitis: 2.8% (34 cases).
    • Control/Other (e.g., febrile convulsions): 75.3%.
  • Among Meningitis Cases (n=224): Bacterial causes accounted for only 5.8%. Aseptic meningitis of unknown etiology was the most common diagnosis (58.5%).
• Pathogen Specifics:
  • Bacterial: Streptococcus pneumoniae was dominant (7/13 cases).
  • Viral: Enterovirus (EV) was predominant (52/80 cases), followed by Parechovirus (9 cases).
  • Encephalitis: Only 24.5% (13/53) of confirmed/probable encephalitis cases had an identified infectious etiology.
• Biomarker Performance:
  • CRP: Highest discriminatory accuracy (AUC 0.919). Optimal cut-off ≥50.7 mg/L (Sensitivity 84.6%, Specificity 85.9%).
  • Procalcitonin (PCT): AUC 0.852. Cut-off ≥3.35 ng/mL (Sensitivity 90.0%, Specificity 85.8%).
  • IL-6: Lower accuracy (AUC 0.782).
• Prediction Score Performance:
  • Bacterial Meningitis Score (BMS): Sensitivity 80.0%, Specificity 57.6%. High Negative Predictive Value (NPV 99.6%) but low Positive Predictive Value (PPV 2.0%).
  • UK-ChiMES Pre-LP Score: Superior performance. Sensitivity 84.6%, Specificity 86.3%, NPV 99.8%, PPV 6.4%.
  • UK-ChiMES Post-LP Score: Sensitivity 76.9%, Specificity 92.7%.
  • Note: The UK-ChiMES Pre-LP score outperformed the BMS by achieving higher specificity while maintaining high sensitivity, reducing false positives.

5. Significance and Clinical Implications

• Rarity of Bacterial Meningitis: In the modern era of vaccination and molecular diagnostics, bacterial meningitis is rare (1.1% of all suspected cases, 5.8% of meningitis cases). This suggests that the threshold for LP and empirical antibiotic therapy may need re-evaluation to avoid over-treatment.
• Risk Stratification Utility: Clinical prediction scores are essential tools. The UK-ChiMES Pre-LP score is recommended as the preferred tool for risk stratification. Its high specificity and NPV suggest it can safely guide clinicians in ruling out bacterial meningitis, potentially reducing unnecessary LPs and antibiotic exposure.
• Diagnostic Challenges: Despite multiplex PCR, the majority of encephalitis cases remain etiologically unresolved. This underscores the need for further research into novel pathogens (e.g., via metagenomic sequencing) and the limitations of current diagnostic panels.
• Shift in Pathogen Profile: The data confirms a shift toward viral etiologies (Enterovirus, Parechovirus) and a significant burden of "aseptic" cases of unknown origin, reflecting the success of bacterial vaccination programs.

Conclusion: The study concludes that in contemporary pediatric practice, bacterial meningitis is a rare event. The UK-ChiMES Pre-LP score offers the most favorable balance of sensitivity and specificity for risk stratification, potentially serving as a critical decision-support tool to optimize diagnostic workflows and antimicrobial stewardship.